Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03897712 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03897712 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 84 participants.
The verdict
NCT03897712, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study is to evaluate the safety and efficacy of Bausch + Lomb custom samfilcon B (test) lens compared to the hioxifilcon D, 54% water, Alden Optical HP Sphere (control) lens when worn by participants who wear soft contact lens on a daily basis.
Interventions
- DEVICE Custom Samfilcon B Contact Lenses
- DEVICE Alden Optical HP Sphere Contact Lens
- DEVICE ReNu MultiPlus Lubricating and Rewetting Drops
- DEVICE Biotrue Multi-Purpose Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-02-27 |
| Est. Completion | 2019-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03897712
The ClinicalTrials.gov registry entry for NCT03897712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Custom Samfilcon B Contact Lenses is the first listed.
NCT03897712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03897712 about?
NCT03897712 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens". This study is to evaluate the safety and efficacy of Bausch + Lomb custom samfilcon B (test) lens compared to the hioxifilcon D, 54% water, Alden Optical HP Sphere (control) lens when worn by participants who wear soft contact lens on a daily basis.
What is the current status of trial NCT03897712?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-02-27. Estimated completion is 2019-08-28.
What interventions are being tested in trial NCT03897712?
The interventions under investigation include: Custom Samfilcon B Contact Lenses (DEVICE), Alden Optical HP Sphere Contact Lens (DEVICE), ReNu MultiPlus Lubricating and Rewetting Drops (DEVICE), Biotrue Multi-Purpose Solution (DEVICE).
Who is sponsoring clinical trial NCT03897712?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.